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IntroductIon
Tuberculosis (TB) has prevailed for millennia and remains a major global health problem. It causes epidemic health issues for approximately 10 million people each year. For the past 5 years, it has been the prominent cause of death from a single infectious agent, ranking above HIV/AIDS. [1] Approximately 10.4 million people fell into suffering with TB in 2016, of which 90% were adults, 65% were male, 10% were people living with HIV (74% in Africa), and 56% were in five countries: India, Indonesia, China, the Philippines, and Pakistan. [1] The major threat in combating TB is increasing multidrug-and extensively drug-resistant cases. Although anti-TB drugs such as isoniazid, rifampicin, ethambutol, and streptomycin were introduced till the 1980s, reporting 98% chances of cure, [2] they have major serious side effects such as psychosis, mental confusion, coma, convulsive seizures, vasculitis, clinical hepatitis, and peripheral neuropathy, [3] and the drug targets of these drugs are found to be mutated in most of the drug-resistant clinical strains of Mycobacterium tuberculosis (MTB) leading to drug-resistant TB. There are different studies across the world for identification of drug targets in MTB. As MTB cell wall is mainly associated with its survival, growth, permeability, virulence, and resistance to antibiotics, it is reported as the versatile fountain of drug targets in MTB. [4] Anishetty et al. identified 185 distinct drug targets in MTB through metabolic pathway analysis. [5] Further, Amir et al. identified 55 drug targets in five unique pathways of MTB through in silico approach. [6] Vashisht et al. also proposed the interactome-driven drug target identification in MTB. [7] There are many studies in India showing the inhibitory effect of phytochemicals on MTB growth. Raju et al. studied the antifolate activity of plant polyphenols against MTB. [8] Lauric acid and myristic acid from Allium sativum also reported to inhibit the growth of MTB H 37 Ra [9, 10] screened and evaluated five medicinal legumes for antitubercular activity through in vitro study. Gupta et al. also evaluated the anti-TB activity of Alpinia galanga L. axenically under reducing oxygen conditions and in intracellular assays. [11] Jha et al. also proposed the anti-TB activity of alkaloids in leaves of Justicia adhatoda. [12] Zhang and Amzel described a list of new drug candidates along with proposed targets for TB intervention. [13] Structural and functional aspects of enzymes present in MTB peptidoglycan biosynthesis proposed as potential targets for drug development. [14] Hosen et al. performed in silico identification and characterization of novel drug targets in F11 clinical strain of MTB. [15] Melak and Gakkhar employed protein-protein interaction network analysis for identification of nonhomologous protein targets of MTB. [16] Further, proteases of MTB also proposed as potential drug targets. [17] Further, different proteins of MTB, namely KasA, [18] Rv2971 (probable oxidoreductase), [19] cytochrome P450, [20] glutamine synthetase, [21] and cyclopropane mycolic acid synthase 1, [22] have been proposed as potential drug targets for MTB. Bunalema et al. studied the inhibitory effect of crude root bark extracts of Erythrina abyssinica on rifampicin-resistant MTB. [23] Luo et al. performed the antimycobacterial evaluation and phytochemical investigation of selected medicinal plants traditionally used in Mozambique. [24] Tan et al. reported the anti-TB activity of triterpenes and phytosterols from Pandanus tectorius Soland. var. laevis. [25] Wächter et al. showed the growth inhibition of MTB bacilli by saringosterol from Lessonia nigrescens. [26] There is an urgent need of new anti-TB drug as the death rate due to TB and multidrug-and extensively drug-resistant cases are increasing day by day. [27] Discovery of a new drug, with minimal side effects, may find a ray of hope to control TB. Thus, in this study, instead of targeting only a single drug target of MTB, we aim to target all possible drug targets of MTB obtained computationally through subtractive genomic/ proteomic approach. As there are different phytochemicals reported in literature and online resources, with anti-TB activity, in silico screening of identified phytochemicals against all possible drug targets was performed to identify a list of potential phytochemicals showing better inhibition against most of the targets.
Methods

Hardware and software
Dell workstation with Windows operating system, having a hard disc of 1 TB and 8 GB RAM, was used for this in silico study. Further, computational analysis was performed using bioinformatics tools such as AutoDockTools 1.5.4, [28] AutoDock Vina 1.1.2, [29] PyMol molecular visualization packages [30] and online resources.
Data mining
Database of essential genes (DEG) contains all the essential genes currently available. By analyzing all the essential genes in DEG, some principles or regulations could be found to answer the question of what are the basic functions necessary to support cellular life. Those principles could lead to the development of new algorithms to predict essential genes. Some functions encoded by essential genes are expected, such as DNA replication, gene transcription, protein synthesis, energy production, and cell division. Analysis of DEG, which has all essential genes among different organisms, could help to classify those "unexpected" essential genes. [31] We explored the DEG and found a total of 614 essential genes for H 37 Rv strain. Subsequently, handling of the 614 genes in PANTHER database [32] was done for functional annotation. PANTHER database is an abundant store of protein families that have been subdivided into functionally related subfamilies, developed using human intelligence. The latest version contains 15,524 protein families, divided into 79,562 functionally distinct protein subfamilies, which covers approximately 90% of mammalian protein-coding genes. [33] The functionally annotated genes obtained from PANTHER database analysis were subjected to Venny [33] for getting multifunctional protein-coding genes. The multifunctional protein-coding genes were further subjected to NCBI BLAST program [34] against Homo sapiens for getting the nonhomologous genes.
Ligand dataset preparation
Evidence from numerous observational and clinical studies suggests that different phytochemicals such as amentoflavone, tiliacorine, sesamin, β-sitosterol, Mauritine M, orientin, and ramontoside have antibacterial and antimycobacterial properties. For screening of drugs, around 700 known anti-TB phytochemicals identified from different sources such as Dr. Duke's Phytochemical and Ethnobotanical Databases, BioPhytMol (a manually curated drug discovery community resource on antimycobacterial phytomolecules and plant extracts), [35] and different literature surveys [36] [37] [38] [39] [40] are considered for this proposed study. A total of 148 phytochemicals were selected from online resources and literature study. The chemical structure files were retrieved from NCBI PubChem database. [41] 
Prediction of protein structure and its validation
The three-dimensional (3D) structure of selected proteins was predicted using Phyre2 server. The 3D structure was subjected to structure validation using ProSA-web, [42] Protein Quality Predictor (ProQ), [43] and Research Collaboratory for Structural Bioinformatics (RCSB) validation server. [44] Phyre2 is an assembly of tools available on the web to predict and analyze protein structure, function, and mutations. [45] AutoDockTools 1.5.4 program (ADT, Molecular Graphics Lab at The Scripps Research Institute, North Torrey Pines Road, La Jolla, California, USA) was used to prepare receptor molecule (Glf) by adding all hydrogen atoms into the carbon atoms of the receptor. Kollman charges were also assigned, and the entire receptor molecules were converted to protein data bank extension file format (PDBQT).
Binding-site prediction
UniProt [46] database search was performed for getting the active site of identified proteins. Those proteins, whose active site was not reported, were subjected to 3DLigandSite web server for predicting their active site. 3DLigandSite is a web server for the prediction of ligand-binding sites based on successful manual methods used in the eighth round of the Critical Assessment of Techniques for Protein Structure Prediction (CASP8). 3DLigandSite utilizes protein structure prediction to provide structural models for proteins that have not been solved. [47] 
Virtual screening
We advanced for virtual screening of 15 proteins with 148 ligands. Virtual screening prototype is now being widely used for filtering large dataset of compounds for drug discovery. All the 148 compounds were subjected to virtual screening along with the 15 proteins using AutoDock Vina version 1.1.2 virtual screening program. [28, 29] Molecular docking of all the ligands with target protein was performed on the binding site of substrate. A grid of 30, 30, and 30 points in X, Y, and Z directions was centered on the known active site residues of proteins. Ligands showing the highest binding energy were selected for further analysis.
results and dIscussIon
In silico analysis using different tools is found to be very useful in developing biologic-based therapeutics for different diseases, [48] exploring different genetic information. [49] Further, the computational approach was also found to be helpful in identifying novel potential inhibitors for MTB drug targets and also useful in TB diagnosis to predict drug resistance. [50] Data mining for MTB H 37 Rv strain in DEG database yielded 614 essential genes. Of 614 genes, 301 genes were found to be affecting molecular function (MF) of MTB; 274 genes were found to be actively involved in biological process of MTB; 156 genes were found in various cellular component of MTB; 282 genes were available acting as proteins of various protein classes when casted for functional annotation using PANTHER database. From the available functionally annotated genes from PANTHER database, we filtered 79 multifunctional genes accounting for MF, cellular component, and protein class and involved in biological processes of MTB using Venny. [33] Seventy-nine gene products were subjected to NCBI BLAST against H. sapiens Refseq protein query database which resulted in 30 filtered MTB gene products nonhomologous to H. sapiens. Of 30 gene products, we further shortlisted only 15 proteins those having query coverage and similarity both >70%.
These filtered 15 proteins then undergone molecular modeling using Phyre2 server. Then, we performed the quality analysis of the protein structure using ProSA-web, ProQ, and ProCheck and observed that these protein structures were of good quality based on Ramachandran plot analysis, LGscore, and Z-score [ Table 1 ] Z-plot, Energy Plot, and Ramachandran Plots of all the proteins are shown in Figure 1 .
Further, detailed information on protein name, function, and pathways of 15 proteins are given in Table 2 . We searched for active site/binding site of the 15 proteins in UniProt database where we found that active sites for 8 proteins (Rv2540c, Rv3709c, Rv2981c, Rv1603, Rv2438c, Rv3602c, Rv1416, and Rv1613) were available. Hence, active sites for other 7 proteins (Rv2244, Rv1305, Rv0705, Rv0721, Rv1612, Rv0703, and Rv0716) were predicted using 3DLigandSite server. We advanced further for virtual screening of 15 proteins with 148 ligands using AutoDock Vina software.
This study revealed that 8 of 148 ligands had good interaction with proteins with the lowest binding energy and IUPAC name, CAS registry number and molecular weight of these 8 ligands are given in Table 3 .
In our in silico study, we observed that taraxerol inhibits AcpM with binding energy of − 7.2 Kcal/mol [ Table 4 ]. It is interacting with the receptor by forming three hydrogen bonds [ Figure 2a ]. AcpM is an acyl carrier protein (ACP) reported to involve in meromycolate extension and associated with different pathways of MTB such as fatty acid biosynthesis, fatty acid metabolism, lipid biosynthesis, and lipid metabolism. [51] Further, it is also reported that the ACP domain forms an integral part of the polypeptide, required for fatty acid biosynthesis. [52] Contd... Further, it was observed that carpaine interacted with AroF with the lowest binding energy and had polar contact of 2.7 Å at ARG135 residue of the receptor [ Figure 2b ]. It is reported that AroF is involved in phenylalanine, tyrosine, and tryptophan biosynthesis; metabolic pathways; biosynthesis of secondary metabolites; biosynthesis of antibiotics; and biosynthesis of amino acids. [46] It is also reported that DNA amplification of AroF-encoded CS from MTB (MtCS) shows that CS is bifunctional. [53] Our virtual screening study revealed that amentoflavone inhibits Ask with binding energy of −9.9 Kcal/mol [ Figure 2c ]. The amino acid residues THR156, LEU214, LEU212, ALA205, and ARG355 of Ask protein were formed polar contact with amentoflavone during ligand-protein interaction. It is also reported that catalysis of phosphorylation of the beta-carboxyl group of aspartic acid with ATP is done by Ask to yield 4-phospho-L-aspartate, which is involved in the branched biosynthetic pathway leading to the biosynthesis of amino acids lysine, threonine, isoleucine, and methionine. [51] Further, biosynthesis of aspartate family amino acids, including lysine, threonine, isoleucine, and methionine is also catalyzed by this aspartate kinase (Ask) protein of MTB. [54] Further, it was observed that 13'-bromo-tiliacorinine had a good binding affinity with AtpE and it formed one hydrogen bond with ASP28 residue of AtpE [ Figure 2d ]. The AtpE has an important role in translocation across the membrane which makes it a key component of the F0 channel. It also plays a vital role in oxidative phosphorylation and metabolic pathways. [51] It is also noticed that lassomycin binds to a highly acidic region of the ClpC1 ATPase complex and markedly stimulates its ATPase activity without stimulating ClpP1P2-catalyzed protein breakdown, which is essential for viability of mycobacteria. [55] Further, this in silico approach revealed that the amino acid residues LYS194, ASN329, ARG316, GLU23, and SER201 of DdlA protein were forming polar contact with amentoflavone [ Figure 2e ] and having binding energy of −10.7 Kcal/mol. DdlA catalyzes the ATP-driven ligation of two D-alanine molecules to form the D-alanyl-D-alanine dipeptide and involved in D-alanine metabolism, peptidoglycan biosynthesis, metabolic pathways, and vancomycin resistance. [51] HisA is an important drug target of MTB, involved in both the histidine and tryptophan biosynthetic pathways and also plays a key role in histidine metabolism; phenylalanine, tyrosine, 
Contd... 
and tryptophan biosynthesis; metabolic pathways; biosynthesis of secondary metabolites; antibiotics; and amino acids. [51] Furthermore, it is reported that two specific single-substrate enzymes (HisA and TrpF), sharing a similar (β/α)(8)-barrel scaffold, catalyze two isomerization reactions in histidine and tryptophan biosynthesis. [56] Our virtual screening study revealed that artonin F inhibits the HisA with binding energy of 7.4 kcal/mol and formed polar contact with ARG16 and SER33 of HisA protein [ Figure 2f ].
Further, we observed in our protein-ligand docking study that carpaine interacted with NadE protein with good binding affinity and formed bond with ARG335 residue of NadE protein [ Figure 2g ]. NadE catalyzes the ATP-dependent amidation of deamido-NAD to form NAD and plays a vital role in NAD(+) biosynthesis. [51] Another study revealed that NAD(+) synthetase present in MTB utilizes both glutamine and ammonia to catalyze NAD(+) production. [57] It is reported that the enzyme pantothenate synthetase, PanC, is an essential drug target in MTB. It is essential for the in vitro growth and survival of MTB in the mouse model of infection. [58] Our study revealed that amentoflavone interacted with PanC protein with binding energy of −10.7 Kcal/mol and showed interaction with the receptor by forming H-bonds with four residues of receptor, i.e., GLY46, LYS160, HIS44, and ASN69 [ Figure 2h ]. PanC catalyzes the condensation of pantoate with beta-alanine in an ATP-dependent reaction via a pantoyl-adenylate intermediate and also involved in beta-alanine metabolism, pantothenate and CoA biosynthesis, metabolic pathways, and biosynthesis of secondary metabolites. [51] Further, RibH, RplE, RplW, RpsE, and RpsS were also reported to have essential functions toward the survival of mycobacteria. [51] It is also reported that species-specific ribosomal RNA expansion segments and ribosomal proteins are possessed by ribosomes of MTB. [59] Our in silico study revealed that 13'bromo-tiliacorinine interacted with RibH protein with binding energy of −8.1 Kcal/mol and formed H-bond with TRP27 residue [ Figure 2i ]. Further, 2'nortiliacorinine was observed to bind with RplE [ Figure 2j ] with a binding energy of −8.4 Kcal/mol. In this study, we observed that amentoflavone showed binding affinity of −7.4 Kcal/mol with RplW and formed polar contacts with ILE49 and ASP94 residues [ Figure 2k ]. Our virtual screening study also revealed that 2'nortiliacorinine inhibited RpsE [ Figure 2l ] with binding energy of −7.4 Kcal/mol. We also noticed that the binding energy of diospyrin and RpsS was −8.8 Kcal/mol and it formed polar contact with at VAL60, LEU71, SER38, LYS70, and SER35 residue positions [ Figure 2m ].
TrpA the alpha-subunit is responsible for the aldol cleavage of indoleglycerol phosphate to indole and glyceraldehyde 3-phosphate and involved in L-tryptophan biosynthesis. [51] It is a potential drug target for MTB. [60] The beta-subunit is responsible for the synthesis of L-tryptophan from indole and L-serine and also participates in glycine, serine, and threonine metabolism; phenylalanine, tyrosine, and tryptophan biosynthesis; metabolic pathways; biosynthesis of secondary metabolites; antibiotics; and amino acids. [51] According to another inspection, TrpB is also an essential drug target of MTB. [61] Virtual screening analysis revealed that bonianic acid B inhibiting TrpA by forming polar contacts with VAL160, LEU218, GLY219, VAL220, GLY239, and ILE237 residues of TrpA [ Figure 2n ], whereas amentoflavone shows a good binding affinity with TrpB. It formed polar contacts with TrpB at ARG155, ALA126, ASP319, HIS129, THR204, GLY247, and GLY248 [ Figure 2o ] residues in protein-ligand complex.
The overall analysis of this in silico study revealed that most of the MTB drug targets of MTB such as Ask, DdlA, PanC, RplW, and TrpB were inhibited by amentoflavone, whereas AroF and NadE were inhibited by carpaine. Further, 13'bromo-tiliacorinine inhibits AtpE and RibH, whereas 2'nortiliacorinine inhibits RplE and RpsE of MTB.
conclusIon
This study shows the usefulness of computational approach for finding effective drug targets of MTB and effective inhibitors from large dataset of phytochemicals. In this study, we explored different resources to identify important drug targets of MTB and further explored 148 different phytochemicals with known anti-TB activity. We identified four phytochemicals such as amentoflavone, carpaine, 13-bromo-tiliacorinine, and 2-nortiliacorinine showing better binding affinity against multiple drug targets of MTB. These compounds may be proposed as potential drug candidates of MTB, and their anti-TB activity needs to be confirmed through in vitro TB culture study.
